Kite Pharma, Inc. Additional Paid in Capital
Kite Pharma, Inc. had Additional Paid in Capital of $469.77 million as of 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapital · last filed 2015-08-10
- 2015-06-30: Additional Paid in Capital $469.77M.
- 2015-03-31: Additional Paid in Capital $459.43M.
- 2014-12-31: Additional Paid in Capital $420.85M.
- 2014-09-30: Additional Paid in Capital $238.23M.
| Period end | Additional Paid in Capital |
|---|---|
| 2015-06-30 | $469.77M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $459.43M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $420.85M 10-Q · filed 2015-08-10 |
| 2014-09-30 | $238.23M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $234.81M 10-Q · filed 2014-08-14 |
| 2013-12-31 | $36.99M 10-K · filed 2015-03-26 |